NBRV - Nabriva Therape Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (-1.38%) TSLA (-2.23%) BA (-2.67%) CELH (0.68%) ETHUSD (%) FCEL (-10%) FVRR (-1.09%) GE (-2.83%) LMND (-6.79%) MARA (-8.39%) RDFN (-1.18%) RIOT (-10.8%) VIVE (-0.32%) VMW (-0.55%) ZM (0.34%) CDEV (0.21%) BTCUSD (%) BLDP (-10.79%) BIOL (-8.88%) BIDU (-4.07%) BABA (0.2%) DASHUSD (%) DASH (-9.7%) CURI (6.83%) CTK (-2.17%)

Recommendation

Service : Small Cap Trader | Trader : James Bills | Trade Date : 11/25/20

$NBRV - Nabriva Therapeutics plc

Buy Long

Trade

192.40 %

Target

$4.28

Issue Price

$12.50

Target Price

11/25/21

Target Date

$2.50

Stop Loss

Trade Closed

Hit Stop Loss

Reason

-43.16 %

P/L %

$2.43

Close Price

15

Days Held

12/11/20

Closed Date

To view trade details and get more recommendations from this trader Follow

NBRV - Nabriva Therapeutics...

$2.92 -0.13[-4.27%]

15 mins delayed data

People also watch : OPHLY | ONCX | OMER

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$3.05	Open	$3.09
Volume	901.9K	Market Cap	45.99M
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: Lilly Secures A...	12/03/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 2) Amic...

Nabriva Therapeutics Earnings, Revenue B...	11/05/20
Nabriva Therapeutics Earnings, Revenue Beat in Q3

The Daily Biotech Pulse: Bluebird Bio Pl...	11/05/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbo...

The Daily Biotech Pulse: Alzheimer's Con...	11/04/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-...

The Daily Biotech Pulse: Aurinia Pulls T...	11/03/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-...

Nabriva Therapeutics to Report Third Qua...	11/02/20
DUBLIN, Ireland, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercializati...

42 Stocks Moving in Thursday's Pre-Marke...	07/16/20
Gainers Nabriva Therapeutics plc (NASDAQ: NBRV ) shares rose 48.9% to ??? Full story available on Benzinga.com

Nabriva inks Sivextro distribution with ...	07/15/20
Nabriva Therapeutics (NASDAQ:NBRV) enters into an agreement with subsidiaries of Merck (NYSE:MRK) granting them exclusive distribution rights to antib...

WEP Clinical Partners With Nabriva Thera...	07/06/20
LONDON--(BUSINESS WIRE)--WEP Clinical (WEP), a specialist pharmaceutical services company, has signed an exclusive agreement with Nabriva Therapeutics...

Attention Biotech Investors: Mark Your C...	07/01/20
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular entity, or NME, ap...

Nabriva Therapeutics (NBRV) Catches Eye:...	06/10/20
Nabriva Therapeutics (NBRV) saw a big move last session, as its shares jumped more than 11% on the day, amid huge volumes.

Implied Volatility Surging for Nabriva (...	06/01/20
Investors need to pay close attention to Nabriva (NBRV) stock based on the movements in the options market lately.

Why Earnings Season Could Be Great for N...	05/07/20
Nabriva Therapeutics (NBRV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season...

Why Nabriva Therapeutics (NBRV) Stock Mi...	04/14/20
Nabriva Therapeutics (NBRV) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well

Will Nabriva Therapeutics Continue to Su...	01/22/20
As of late, it has definitely been a great time to be an investor in Nabriva Therapeutics.

The Daily Biotech Pulse: Xeris Jumps On ...	01/07/20
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o...

Nabriva's stock soars after resubmitting...	12/20/19
Shares of Nabriva Therapeutics PLC soared 10.5% in premarket trading Friday, after the biotechnology company said it resubmitted its new drug applicat...

Biotech Stock On The Radar: Nabriva And ...	11/20/19
Nabriva Therapeutics PLC ??? ADR (NASDAQ: NBRV ) shares have gained about 46% year-to-date. With the average analyst target being $8.42, the shares ar...

Nabriva Therapeutics (NASDAQ:NBRV) Stock...	11/18/19
ValuEngine cut shares of Nabriva Therapeutics (NASDAQ:NBRV) from a hold rating to a sell rating in a report published on Thursday morning, ValuEngine ...

Nabriva Therapeutics (NASDAQ:NBRV) Stock...	11/15/19
Nabriva Therapeutics PLC ??? (NASDAQ:NBRV)???s stock price fell 5% during trading on Friday . The stock traded as low as $1.97 and last traded at $1.8...

iShares NASDAQ Biotechnology Index Fund ...	08/25/19
The biotech space saw a few FDA decisions and clinical readouts over the last week. The FDA handed down two verdicts, backing Nabriva Therapeutics PLC...

Nabriva (NBRV) Gains FDA Approval for Pn...	08/20/19
The FDA approves Nabriva's (NBRV) new drug application for both intravenous and oral formulations of Xenleta to treat adult patients with community-ac...

Nabriva Analysts Bullish After FDA OKs A...	08/20/19
The FDA approved Nabriva Therapeutics PLC ??? ADR (NASDAQ: NBRV )'s lead antibiotic asset, Xenleta, on Monday for the treatment of community-acquired ...

SDRL, BIDU among premarket gainers	08/20/19
Nabriva Therapeutics plc (NBRV) +23%. VIVUS (VVUS) +19% on positive Qsymia data in gastric sleeve surgery. Seadrill (SDRL) +17% on Q2 result. Soliton ...

Nabriva Shares Rip Higher Following FDA ...	08/20/19
Nabriva Therapeutics PLC ??? ADR (NASDAQ: NBRV ) shares are trading sharply higher, riding on the back of a positive FDA verdict on one of its pipelin...

Nabriva Therapeutics' stock soars in hea...	08/20/19
Shares of Nabriva Therapeutics PLC shot up 27% to pace the premarket gainers in active trading Tuesday, after the biotechnology company said its new d...

Nabriva (NBRV) Aims to Resubmit Contepo ...	08/19/19
Nabriva (NBRV) intends to resubmit the NDA for Contepo in Q4. The intravenous candidate is being studied for treating patients with complicated urinar...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	12/07/20
Morgan Stanley maintains Equal-Weight rating and raises Price Target from $2.00 to $20.00

EARNINGS

Date	2020-11-05 (BMO)	Est. (EPS/Rev.)	($0.10)/ 450K
Actual (EPS/Rev.)	$-0.09/ $1.29 M	EPS (TTM)	0

TRADERS TRACKING $NBRV

Service Name	Trader	% Success
Small Cap Trader	James Bills	52.00 %	Follow
Biotechnology	Robert Gadimian	26.00 %	Follow
GOFANG	avinash anantharamu	0.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.